Company Profile

Evotec SE (OTC: EVTCY)
Pricing data not available

Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): n/a
% Price Change (last 13 weeks): n/a
% Price Change (last 26 weeks): n/a
% Price Change (last 52 weeks): n/a
% Price Change (year to date): n/a
Financial Strength
Quick Ratio (x): n/a
Current Ratio (x): n/a
LT Debt/Equity (%): n/a
Total Debt/Equity (%): n/a
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.
Evotec SE
Manfred Eigen Campus, Essener Bogen 7
Hamburg 22419

Phone: +49-40-56081-0
Fax: +49-40-56081-222
http://evotec.com
Cash & Margins
Net Operating Cash Flow (n/a ): n/a
Net Operating Margin (%): n/a
Pretax Profit Margin (%): n/a
Management Effectiveness
Return on Equity (%): n/a
Return on Assets (%): n/a
Return on Invested Capital (%): n/a
Profit and Loss
Sales/turnover (n/a ): n/a
Deprec. & Amoritiz (n/a ): n/a
Operating Income (n/a ): n/a
EPS - Excl. Extraordinary Items: n/a



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.